Multiple Genomic Technologies Validate Rare Novel Variant and Direct Medical Care in Vascular Anomalies
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.64126 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Luciana Daniela Garlisi Torales und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unit on Vascular Malformations, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bet…. Hauptthemen laut MEDLINE: Vascular Malformations, PTEN Phosphohydrolase, Genomics, Hamartoma Syndrome, Multiple. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Children's Hospital of Philadelphia Frontier Program Grant.
Abstract (Originalsprache)
Some vascular anomalies, such as hamartomas associated with PTEN hamartoma tumor syndrome (PHTS) and fibroadipose vascular anomaly (FAVA, often due to PI3KCA variants), share similar clinical, radiological, and histopathological presentations that challenge clinicians to provide an accurate diagnosis. Genetic testing can help clinicians differentiate these two vascular anomalies to provide proper treatment for patients. An 11‐year‐old female with macrocephaly presented with a painful lesion in her right ankle and was initially diagnosed with FAVA and treated with sirolimus. Initial genetic testing from a biopsy sample was negative. Subsequently, however, repeat clinical genetic testing and research deep exome sequencing from a second tissue biopsy sample identified a mosaic variant in PTEN (NM_00314.7) c.683delA p.Asn228Ilefs*28 with a variant allele fraction (VAF) of 2.0%–2.1%, ultimately changing the diagnosis from FAVA to a PTEN hamartoma. To evaluate the germline status of this patient, PTEN sequencing and deletion duplication testing was sent from saliva and identified a different variant in PTEN (NM_000314.4) c.202_209+18delins27, estimated to be 20%–30% VAF. Sanger sequencing validated this novel variant as germline, leading to cancer screening in the patient. This case exemplifies the need for genetic reevaluation as sequencing technology continues to update rapidly, repeat sampling in cases of suspected mosaicism, the two‐hit hypothesis in the development of vascular malformations, and emphasizes the importance of genetic diagnosis in vascular malformations, especially in this case which led to the identification of a cancer predisposition syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit on Vascular Malformations, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA.
- Comprehensive Vascular Anomalies Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- University of Pennsylvania Genetic Diagnostic Laboratory, Philadelphia, Pennsylvania, USA.
- Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Allison Britt, Abhay Srinivasan, Suzanne P MacFarland, Sarah E Sheppard
Förderung
- Intramural NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Children's Hospital of Philadelphia Frontier Program Grant
Zitieren
APA
Torales, L. D. G., Woodis, K., Britt, A., Surrey, L. F., Srinivasan, A., Ganguly, A., Limmina, M., Li, D., MacFarland, S. P., Adams, D. M., & Sheppard, S. E. (2025). Multiple Genomic Technologies Validate Rare Novel Variant and Direct Medical Care in Vascular Anomalies. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64126
Vancouver
Torales LDG, Woodis K, Britt A, Surrey LF, Srinivasan A, Ganguly A, et al. Multiple Genomic Technologies Validate Rare Novel Variant and Direct Medical Care in Vascular Anomalies. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64126
BibTeX
@article{Torales2025,
author = {Torales, Luciana Daniela Garlisi and Woodis, Kristina and Britt, Allison and Surrey, Lea F and Srinivasan, Abhay and Ganguly, Arupa and Limmina, Maria and Li, Dong and MacFarland, Suzanne P and Adams, Denise M and Sheppard, Sarah E},
title = {Multiple Genomic Technologies Validate Rare Novel Variant and Direct Medical Care in Vascular Anomalies},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.64126}
}
EUVIMED